Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically

por Giliberto, Mariaserena, Thimiri Govinda Raj, Deepak B., Cremaschi, Andrea, Skånland, Sigrid S., Gade, Alexandra, Tjønnfjord, Geir E., Schjesvold, Fredrik, Munthe, Ludvig A., Taskén, Kjetil
Publicado 2022

Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B‐cell malignancies

por Melvold, Katrine, Giliberto, Mariaserena, Karlsen, Linda, Ayuda‐Durán, Pilar, Hanes, Robert, Holien, Toril, Enserink, Jorrit, Brown, Jennifer R., Tjønnfjord, Geir E., Taskén, Kjetil, Skånland, Sigrid S.
Publicado 2021

Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines

por Giliberto, Mariaserena, Santana, Leonardo Miranda, Holien, Toril, Misund, Kristine, Nakken, Sigve, Vodak, Daniel, Hovig, Eivind, Meza-Zepeda, Leonardo A., Coward, Eivind, Waage, Anders, Taskén, Kjetil, Skånland, Sigrid S.
Publicado 2022

P613: ANALYSIS OF EX-VIVO RESPONSE TO SINGLE DRUGS AND DRUG COMBINATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENT SAMPLES

por Miranda Santana, Leonardo, B. Thimiri Govinda Raj, Deepak, Cremaschi, Andrea, Giliberto, Mariaserena, Gade, Alexandra, Frigessi, Arnoldo, E. Tjønnfjord, Geir, A. Munthe, Ludvig, S. Skånland, Sigrid, Zucknick, Manuela, Taskén, Kjetil
Publicado 2023

Standardized assays to monitor drug sensitivity in hematologic cancers

por Ayuda-Durán, Pilar, Hermansen, Johanne U., Giliberto, Mariaserena, Yin, Yanping, Hanes, Robert, Gordon, Sandra, Kuusanmäki, Heikki, Brodersen, Andrea M., Andersen, Aram N., Taskén, Kjetil, Wennerberg, Krister, Enserink, Jorrit M., Skånland, Sigrid S.
Publicado 2023